Skip to main
NHI
NHI logo

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. has experienced a positive outlook, reflected by an increase in normalized Funds From Operations (NFFO) estimates for 2025, now projected at $4.80 per share, which aligns with management's guidance range. A similar upward adjustment has been made for the 2026 FFO estimate, which now stands at $5.03 per share, slightly exceeding the $5.00 consensus. The company's solid performance and encouraging outlook from management, particularly following a strong second quarter, reinforce optimism regarding its revenue generation capabilities and market position within the senior housing sector.

Bears say

National Health Investors Inc. is projected to experience lower earnings growth over the upcoming years, primarily due to challenges that may arise from operator transitions and issues that hinder profitability. The performance of the company's stock may be negatively impacted if the NHC rent reset falls short of investor expectations or if deferred rent collections weaken. Additionally, potential risks include operational difficulties faced by its operators, particularly in the context of health crises such as another pandemic, which could further strain revenue generation.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.